News | January 16, 2023
China, South Korea, and India driving innovation in medical robotics in APAC, says GlobalData
APAC to see a reduction in imported surgical robotics
APAC to see a reduction in imported surgical robotics
The cardiomyopathies market in the 68M is set to grow at a CAGR of 12.1%
APAC region contributed around 50% of the in-vitro diagnostics market in 2022
He urged the dignitaries to collaboratively work on the identified domains of improvement and make detailed reports on them
China has the highest number of clinical trials that were initiated in NAFLD in the APAC region over the past decade.
The balance of AUD 94 Million was a deferred consideration backed by a secured interest-bearing instrument
Allam was serving recently as the CEO at Public Investment Fund
36.4% of patients with diabetic neuropathic pain in 2021 were completely treatment refractory and would benefit from new treatment options.
China is now focusing on establishing volume and enhancing capabilities for innovative high value drug production
GlobalData predicts the average prices of dual chamber pacemakers in both India and China are expected to reduce at an average CAGR of -3.42% from 2022 to 2025.
Subscribe To Our Newsletter & Stay Updated
